After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Arcutis Biotherapeutics Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Arcutis Biotherapeutics Inc is $2.40B. A total of 1.82 million shares were traded on the day, compared to an average of 1.78M shares.
In the most recent transaction, Edwards Larry Todd sold 4,504 shares of ARQT for 20.04 per share on Oct 02 ’25. After the transaction, the insider now owns 178,897 company shares. In a previous transaction on Oct 01 ’25, Watanabe Todd sold 24,261 shares at 19.33 per share. ARQT shares that the insider owns now total 867,179.
Among the insiders who sold shares, Watanabe Todd disposed of 20,739 shares on Oct 02 ’25 at a per-share price of $20.04. This resulted in the insider holding 846,440 shares of ARQT after the transaction. In another insider transaction, Welgus Howard G. sold 10,000 shares at $18.92 per share on Oct 01 ’25. Company shares held by the Director now total 99,744.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ARQT has a high of $21.56 and a low of $8.03.
As of this writing, ARQT has an earnings estimate of -$0.1 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.05 per share and a lower estimate of -$0.13. The company reported an EPS of -$0.33 in the last quarter
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ARQT’s latest balance sheet shows that the firm has $387.06M in Cash & Short Term Investments as of fiscal 2021. There were $77.56M in debt and $33.33M in liabilities at the time. Its Book Value Per Share was $1.16, while its Total Shareholder’s Equity was $297.68M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock.
